ULIVI, PAOLA
 Distribuzione geografica
Continente #
AS - Asia 3.708
NA - Nord America 1.890
EU - Europa 1.357
SA - Sud America 226
Continente sconosciuto - Info sul continente non disponibili 157
AF - Africa 124
OC - Oceania 6
Totale 7.468
Nazione #
US - Stati Uniti d'America 1.816
CN - Cina 1.040
SG - Singapore 989
VN - Vietnam 743
IT - Italia 418
HK - Hong Kong 276
DE - Germania 265
KR - Corea 223
BR - Brasile 164
BD - Bangladesh 156
NL - Olanda 147
SE - Svezia 129
FR - Francia 109
IN - India 98
GB - Regno Unito 80
JP - Giappone 56
FI - Finlandia 51
CI - Costa d'Avorio 50
CA - Canada 41
IE - Irlanda 32
RU - Federazione Russa 30
AR - Argentina 29
ID - Indonesia 28
MX - Messico 22
PH - Filippine 21
BG - Bulgaria 20
SC - Seychelles 20
AT - Austria 14
ZA - Sudafrica 14
TG - Togo 13
TH - Thailandia 13
JO - Giordania 12
UA - Ucraina 12
BE - Belgio 11
TR - Turchia 11
CH - Svizzera 8
CO - Colombia 7
EC - Ecuador 7
PL - Polonia 7
IQ - Iraq 6
MA - Marocco 6
TW - Taiwan 6
AU - Australia 5
LT - Lituania 5
PE - Perù 5
PY - Paraguay 5
UZ - Uzbekistan 5
KE - Kenya 4
CR - Costa Rica 3
ES - Italia 3
JM - Giamaica 3
NP - Nepal 3
SA - Arabia Saudita 3
TN - Tunisia 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BO - Bolivia 2
CL - Cile 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EE - Estonia 2
EG - Egitto 2
HR - Croazia 2
LB - Libano 2
MU - Mauritius 2
MY - Malesia 2
NG - Nigeria 2
PK - Pakistan 2
AD - Andorra 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BZ - Belize 1
CW - ???statistics.table.value.countryCode.CW??? 1
GA - Gabon 1
GE - Georgia 1
GH - Ghana 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HU - Ungheria 1
IL - Israele 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LS - Lesotho 1
MD - Moldavia 1
ME - Montenegro 1
ML - Mali 1
NZ - Nuova Zelanda 1
OM - Oman 1
PT - Portogallo 1
RS - Serbia 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
VC - Saint Vincent e Grenadine 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.311
Città #
Singapore 763
Hefei 531
San Jose 293
Ashburn 272
Hong Kong 266
Seoul 217
Ho Chi Minh City 208
Hanoi 155
Council Bluffs 102
Dallas 76
Amsterdam 73
Los Angeles 68
Santa Clara 67
Beijing 61
Fairfield 56
Lauterbourg 54
New York 52
Chandler 51
Abidjan 50
Bengaluru 47
Bologna 45
Southend 45
Tokyo 45
Boardman 42
Krefeld 41
Milan 41
Rome 36
Dublin 32
São Paulo 30
Buffalo 28
Dong Ket 28
Wilmington 28
Da Nang 26
Helsinki 26
Munich 26
Frankfurt am Main 25
Seattle 25
Woodbridge 24
Princeton 23
Houston 21
Jakarta 20
Ann Arbor 19
Sofia 19
Chicago 18
Haiphong 18
The Dalles 18
Tongling 18
Lappeenranta 17
Redondo Beach 17
Turin 16
Bad Bellingen 15
Guangzhou 15
Cambridge 14
Lomé 13
Potenza 13
Amman 12
Biên Hòa 12
Hải Dương 11
Mexico City 11
Naples 11
Nuremberg 11
Rimini 11
Shanghai 11
Can Tho 10
Falkenstein 10
Johannesburg 10
Orem 10
Vienna 10
Bắc Ninh 8
Düsseldorf 8
Montreal 8
Salt Lake City 8
Turku 8
Berlin 7
Cesena 7
Delhi 7
Ha Long 7
Hillsboro 7
Nanjing 7
San Francisco 7
Tianjin 7
Toronto 7
Xi'an 7
Brooklyn 6
Brussels 6
Columbus 6
Florence 6
Jacksonville 6
London 6
Miami 6
Nha Trang 6
Paris 6
Quận Bình Thạnh 6
Redmond 6
Rio de Janeiro 6
Stockholm 6
Tampa 6
Baghdad 5
Charlotte 5
Denver 5
Totale 4.698
Nome #
HDAC6 as a Prognostic Factor and Druggable Target in HER2-Positive Breast Cancer 320
Impact of Somatic DNA Repair Mutations on the Clinical Outcomes of Bone Metastases from Castration-Resistant Prostate Cancer 288
ANGPT2 and NOS3 polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients receiving sorafenib 245
Schedule-dependent cytotoxic interaction between Epidoxorubicin and Gemcitabine in human bladder cancer cells in vitro. 234
Gene duplication, rather than epigenetic changes, drives FGF4 overexpression in KIT/PDGFRA/SDH/RAS-P WT GIST 208
Inherited Mutations in DNA Damage Repair Genes in Italian Men with Metastatic Prostate Cancer: Results from the Meet-URO 10 Study 203
Cell-Free DNA Fragmentomics: A Promising Biomarker for Diagnosis, Prognosis and Prediction of Response in Breast Cancer 186
Dynamic Monitoring of Circulating Tumor DNA in Patients With Metastatic Colorectal Cancer 185
Tumor-Infiltrating Lymphocytes (TILs) and Risk of a Second Breast Event After a Ductal Carcinoma in situ 184
An Italian Real-World Study Highlights the Importance of Some Clinicopathological Characteristics Useful in Identifying Metastatic Breast Cancer Patients Resistant to CDK4/6 Inhibitors and Hormone Therapy 181
Clinical Impact of Next-Generation Sequencing Multi-Gene Panel Highlighting the Landscape of Germline Alterations in Ovarian Cancer Patients 175
The Interplay Between Programmed Death Ligand 1 and Vimentin in Advanced Non-Small-Cell Lung Cancer 171
High Levels of Circulating Monocytic Myeloid-Derived Suppressive-Like Cells Are Associated With the Primary Resistance to Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: An Exploratory Analysis 165
Liquid Biopsy for EGFR Mutation Analysis in Advanced Non-Small-Cell Lung Cancer Patients: Thoughts Drawn from a Real-Life Experience 160
Primary Mediastinal and Testicular Germ Cell Tumors in Adolescents and Adults: A Comparison of Genomic Alterations and Clinical Implications 159
Clinicopathological Features of Non-Small Cell Lung Carcinoma with BRAF Mutation 158
Clinical and circulating biomarkers of survival and recurrence after radiofrequency ablation in patients with hepatocellular carcinoma 157
Genomic Profiling of Extensive Stage Small-Cell Lung Cancer Patients Identifies Molecular Factors Associated with Survival 156
Impressive clinical response to anti-PD-1 therapy in epithelioid mesothelioma with high clonal PD-L1 expression and EML4-ALK rearrangement 154
Association of NOS3 and ANGPT2 Gene Polymorphisms with Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib: Results of the Multicenter Prospective INNOVATE Study 152
Wide Next-Generation Sequencing Characterization of Young Adults Non-Small-Cell Lung Cancer Patients 151
Genetic and epigenetic alterations of cdh1 regulatory regions in hereditary and sporadic gastric cancer 150
Liquid biopsy perspectives in pleomorphic carcinoma of the lung: case report. 149
Neoadjuvant endocrine therapy for luminal breast tumors: State of the art, challenges and future perspectives 149
The Role of TP53 Mutations in EGFR-Mutated Non-Small-Cell Lung Cancer: Clinical Significance and Implications for Therapy 147
Circulating Tumour Cells: Detection and Application in Advanced Non-Small Cell Lung Cancer 146
Genetic Predisposition to Colorectal Cancer: How Many and Which Genes to Test? 143
Rare Driver Mutations in Advanced, Oncogene-Addicted Non-Small Cell Lung Cancer: A North Italian, Real-World, Registry Experience 140
Genomic events stratifying prognosis of early gastric cancer 140
Inflammatory indices as prognostic markers in metastatic colorectal cancer patients treated with chemotherapy plus Bevacizumab 138
Role of circulating microRNAs to predict hepatocellular carcinoma recurrence in patients treated with radiofrequency ablation or surgery 134
The Clinical Significance of Circulating Tumor DNA for Minimal Residual Disease Identification in Early-Stage Non-Small Cell Lung Cancer 129
Epigenetic mechanisms in gastric cancer: Potential new therapeutic opportunities 128
Moving beyond parp inhibition: Current state and future perspectives in breast cancer 126
Immunosenescence in Testicular Cancer Survivors: Potential Implications of Cancer Therapies and Psychological Distress 121
Increased levels of free circulating DNA in patients with idiopathic pulmonary fibrosis 120
Sorafenib and Regorafenib in HBV- or HCV-positive hepatocellular carcinoma patients: Analysis of RESORCE and SHARP trials. 119
The role of next-generation sequencing in detecting gene fusions with known and unknown partners: a single-center experience with methodologies’ integration 118
Prognosis of ALK-rearranged non-small-cell lung cancer patients carrying TP53 mutations 116
Combining preclinical tools and models to unravel tumor complexity: Jump into the next dimension 115
Impact of Baseline Characteristics on the Overall Survival of HCC Patients Treated with Sorafenib: Ten Years of Experience 112
Genomic and Transcriptomic Profiles in Smokers and Never-Smokers Lung Squamous Cell Carcinoma Patients 106
Longitudinal assessment of plasma androgen receptor copy number predicts overall survival in subsequent treatment lines in castration-resistant prostate cancer: analysis from a prospective trial 94
Liquid Biopsy Identifies Taxane Resistance and Clonal Selection in Castration-Resistant Prostate Cancer 93
New generation anaplastic lymphoma kinase inhibitors 88
Role of liquid biopsy in oncogene-addicted non-small cell lung cancer 84
Identification of a novel large EPCAM-MSH2 duplication, concurrently with LOHs in chromosome 20 and X, in a family with Lynch syndrome 78
Prospective validation of VEGF and eNOS polymorphisms as predictors of first-line bevacizumab efficacy in patients with metastatic colorectal cancer 71
Changing metastatic patterns associate with dynamics of circulating tumor DNA in metastatic castration-resistant prostate cancer 65
Mutational and low-coverage whole genome sequencing identifies actionable DNA repair alterations in prostate cancer plasma DNA 57
Investigating biochemical markers of Acupuncture's effectiveness in managing climacteric syndrome in breast cancer patients: the FLAIR study 41
Corrigendum to “Neoadjuvant endocrine therapy for luminal breast tumors: State of the art, challenges and future perspectives” [Crit. Rev. Oncol./Hematol. 181 (2023) 103900] (Critical Reviews in Oncology / Hematology (2023) 181, (S1040842822003249), (10.1016/j.critrevonc.2022.103900)) 35
Targeting RET-rearranged non-small-cell lung cancer: future prospects 24
Totale 7.468
Categoria #
all - tutte 17.994
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.994


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022241 0 0 16 24 18 6 4 31 7 17 80 38
2022/2023283 17 42 17 27 18 27 4 21 63 4 22 21
2023/2024311 7 20 9 9 28 17 21 13 159 10 11 7
2024/20251.323 61 89 54 92 80 41 30 34 42 197 201 402
2025/20264.753 515 731 532 395 333 137 480 216 661 272 316 165
2026/2027251 108 143 0 0 0 0 0 0 0 0 0 0
Totale 7.468